Yahoo Web Search

Search results

  1. 3 days ago · Bringing Bassey back for $2.2 million is a good way to add to an area of need at a reduced price but there is a detail in the big man's contract that will help him and San Antonio get where they ...

  2. 3 days ago · The Spurs’ lack of quality big man depth could be their biggest weakness in 2024/25. The Spurs will need Zach Collins and Charles Bassey to step up when Victor Wembanyama rests, but whether they ...

  3. 4 days ago · ependable veterans like Chris Paul and Harrison Barnes, selecting talented prospects like Stephon Castle and Harrison Ingram, and retaining a couple of familiar faces like Charles Bassey and Sandro Mamukelashvili, the Spurs have done an astounding balancing act of upgrading their depth chart while maintaining continuity.

  4. 3 days ago · Spurs center Charles Bassey gave up his right to veto a trade during the 2024/25 league year, Hoops Rumors has learned. A player who re-signs with his previous team on a one-year contract (or a two-year deal with a second-year option) is typically given a de facto no-trade clause for the season, but that right can be waived as part of a contract agreement.

  5. 1 day ago · The NBA offseason officially began at 12:01 a.m. ET on June 28 following the completion of the 2024 NBA Draft. NBA free agency tipped off on June 30 at 6 p.m. ET with players and...

  6. 2 days ago · July 23, 2024 9:03 pm CT. Are the San Antonio Spurs building a team the right way around star forward Victor Wembanyama? So far, since the ball club drafted the generational French talent, they have added talent to the team via the NBA draft. They picked up University of Connecticut combo guard Stephon Castle, University of North Carolina ...

  7. 4 days ago · By BVM Sportsdesk, 2h ago. The Spurs may face a significant challenge in the 2024/25 season due to a lack of quality depth in the big man position, particularly behind starting center Victor Wembanyama. Zach Collins and Charles Bassey are expected to fill this role, but their effectiveness remains uncertain. By the Numbers.